Elsevier

Materials Today Nano

Volume 11, August 2020, 100084
Materials Today Nano

Magnetic nanoparticles in regenerative medicine: what of their fate and impact in stem cells?

https://doi.org/10.1016/j.mtnano.2020.100084Get rights and content

Highlights

  • The potential benefits of magnetic nanoparticles for regenerative medicine applications are undeniable.

  • Is there a direct toxicity upon internalization in cells? In particular regarding stem cells differentiation?

  • Stem cells can assimilate the nanoparticles, store the iron released from their degradation in endogenous ferritin and adapt their iron metabolism accordingly.

  • Overall, balancing the long-term cellular risks and theranostic benefits across the use of magnetic nanoparticles within stem cells for regenerative medicine must be carefully faced.

Abstract

With advancing developments over the use of magnetic nanoparticles in biomedical engineering, and more specifically cell-based therapies, the question of their fate and impact once internalized within cells remains crucial. After highlighting the regenerative medicine applications based on magnetic nanoparticles, this review documents their potential cytotoxicity and, more importantly, underscores their valuable features for stem cell differentiation. It then focuses on the transformations magnetic nanoparticles might experience in cells, mainly consisting in their progressive degradation, and assesses the practical pitfalls related to this degradation. First, it may result in a loss of long-term theranostic potential, and second, it drives an adaptation of the cell metabolism to the released iron. Overall, this review demonstrates that magnetic nanoparticles present undeniable interest for stem cell-based biomedical applications; however, each nanoparticle/cell system must be carefully considered for a safe medical use. It also clearly demonstrates that the biodegradation of the nanoparticles and the cell response to the released iron must be systematically assessed.

Introduction

Nanotechnology holds the potential to transform the field of medicine by permitting the development of combined and remote theranostic applications. To this effect, investigations into multiple nanoparticle configurations have been the subject of intensive research, each of which can be readily interfaced with living cells due to their size compatibility, and each possessing exploitable and unique therapeutic properties [1]. Naturally, over 200 nanotechnology-enabled products have already undergone full clinical trials, and the field keeps expanding. Tailored treatments, such as a patient-specific targeted drug release that minimizes systemic toxicity, have become the current focus of nanoparticle-based therapy.

Within this field of research, magnetic nanoparticles are featured prominently in the development of new diagnostic and therapeutic methodologies, where they pose an exciting prospect due to their inherent properties [2,3]. For instance, their ability to generate a local magnetic field makes them relevant as magnetic resonance imaging (MRI) contrast agents [4]. Due to their strong magnetization values, they have been mainly studied as T2 contrast agents, but recent efforts have focused on improving their use as T1 contrast agents while further increasing T2 contrast [[5], [6], [7], [8], [9]]. Magnetic-activated cell sorting (MACS) also uses superparamagnetic nanoparticles with specific targeting antibodies [10] as a standard procedure for the sorting of cell populations, with applications in cancer, stem cell and immunology research, among others [11]. With the advent of microfluidic integration [[12], [13], [14]], magnetic cell sorting has become highly relevant in the field of cancer clinical diagnostics, where it is used and studied for capturing and sorting of circulating tumor cells [[15], [16], [17], [18]]. Magnetic nanoparticles have also been used for cancer therapy via magnetic hyperthermia, or heat generation after exposure to an alternating magnetic field, that is currently under clinical trials for the treatment of prostate carcinoma [19,20] and glioblastoma [21,22]. Recent efforts have focused on the optimization of the heating efficiency by producing new designs [23], such as nanocubes [24] or multicore nanoparticles [25]. Photothermal therapy, a second hyperthermal modality with higher heat generation potential per nanoparticle, has also emerged [[26], [27], [28]].

Recently, the regenerative medicine and tissue engineering fields have found a surge of interest in magnetic nanoparticles, using their magnetomechanical potential as an innovative approach to spatially organize [[29], [30], [31]] and stimulate [32] stem cells. Magnetomechanical forces have for example been used for stem cell differentiation into the chondrogenic [33,34], adipogenic [35] or mesodermal cardiac pathways [36]. In most of these applications, the necessary step to endow the cells with the pursued theranostic properties consists in the internalization of magnetic nanoparticles in their intracellular environment. It should be noted first that nanoparticle internalization does not impair the cellular magnetic force generated, being directly the sum of the magnetic moment of each nanoparticle independently of its location, an essential feature in cell targeting, drug delivery, and tissue engineering applications. What remains to be explored extensively then are the ultimate fate and biotransformations that nanoparticles undergo after cellular uptake and endosomal confinement. Importantly, for most theranostic applications the typically used nanoparticles are iron oxide-based [37], and iron is a naturally occurring bio-element with its own metabolic pathway in mammals. In the organism, it has been described that iron oxide nanoparticles injected intravenously are internalized, mostly in macrophages, then join the iron pool and integrate into the natural iron metabolic pathway. Conversely, the degradation of iron oxide nanoparticles may transform iron oxide into unbound iron ions, which can trigger the generation of reactive oxygen species via the Fenton reaction, leading to oxidative stress and subsequent cell damage [38].

Anti-cancer therapies take advantage of these features by targeting the iron metabolism [39], with the ultimate induction of cell death through ferroptosis [40]. In contrast to this, for regenerative medicine applications, any cell damage must be avoided. The relationship between degradation of magnetic nanoparticles and cellular cytotoxicity is not quite clear yet, or at least has not been directly demonstrated. Besides, it is important to highlight that the biodegradation of magnetic nanoparticles may not only severely impact their long-term stability, it may also decrease their magnetic moment and thus their theranostic potential. Indeed, as shown previously in a stem cell-tissue model, long-term nanoparticle degradation translates into a marked decrease of cell magnetization [41]. Strategies to prevent nanoparticle degradation should then be envisaged to maximize long-term theranostic potential and possibly avoid any source of toxicity. For instance, fine tuning of a gold shell [42,43] or a polymeric coating [44] could shield the nanoparticles from degradation and maintain their integrity and magnetic properties.

Given the upsurge of interest for magnetic nanoparticles in the regenerative medicine field and the challenges imposed by their degradation on their potential cytotoxicity as well as their theranostic applicability, this review will focus on the interplay of these three topics. First, it will summarize the potential of magnetic nanoparticles for regenerative medicine applications, using mostly stem cells as the basis of regeneration, including imaging of stem cell grafts, magnetic stem cell targeting, and tissue engineering, among others. Then, discussion will shift to the impact magnetic nanoparticles may have on the differentiation of stem cells, keeping in mind that differentiation processes take weeks and are an indicator of long-term toxicity. Finally, this review will assess a potential correlation between long-term toxicity, intracellular transformations of the nanoparticles, and the alteration in the expression of genes related to iron metabolism. The aim is to draw up the most comprehensive inventory of the reported quantified changes in cellular iron metabolism with time.

Section snippets

Magnetic nanoparticles for cell-based therapies and regenerative medicine

Magnetic nanoparticles have a direct applicative potential in biomedicine (Fig. 1). They were first developed as contrast agents for MRI, and their range of applications keeps expanding. The number of clinical trials and the increasing amount of products approved by regulatory boards indicate this growing interest. Treatments already at disposition in the clinic include MRI contrast agents for liver lesions (Resovist®) or sentinel node detection (Sienna+®), treatment of brain tumors via

Synthesis of magnetic nanoparticles

Numerous chemical methods can be used to synthesize magnetic nanoparticles: coprecipitation of iron salts [[114], [115], [116], [117]], sol-gel synthesis [118] including microwave assisted ones [119], hydrothermal reactions [120], hydrolysis and thermolysis of precursors [121], synthesis in microemulsions [122], flow injection synthesis [123], electrospray synthesis [124] and microfluidic flow synthesis [[125], [126], [127], [128], [129]]. In this review, we will only cover very briefly the

Degradation of magnetic nanoparticles internalized in cells

The first step for most biomedical applications involving magnetic nanoparticles is to internalize them inside the cells, where they are to be left within. Consequently, one mandatory prerequisite prior to clinical translation is to explore their long-term intracellular fate and understand whether they behave as a single indissoluble unit or if they can, on the contrary, be affected by the surrounding biological environment. Primary concerns associated with a possible biodegradation would be

Interplay between nanoparticles degradation, stem cell function, and iron metabolism

Despite the acceptance and popularity of the applicative potential of magnetic nanoparticles in medicine, we must still resolve any issues regarding their impact and fate upon internalization within cells. The answer to this remaining question is not straightforward. Studies comparing several factors two-by-two exist, but a larger study that correlates the dose of internalized nanoparticles, degradation rate, impact of the differentiation pathway and the modulation of expression of iron

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This work was supported by the European Research Council (ERC-2014-CoG project MaTissE #648779).

References (272)

  • P.D. Ray et al.

    Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling

    Cell. Signal.

    (2012)
  • S.J. Dixon et al.

    Ferroptosis: an iron-dependent form of nonapoptotic cell death

    Cell

    (2012)
  • J.W.M. Bulte et al.

    Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model

    Acad. Radiol.

    (2005)
  • A. Ottersbach et al.

    Improved heart repair upon myocardial infarction: combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes

    Biomaterials

    (2018)
  • E. Carenza et al.

    In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies

    Nanomedicine

    (2014)
  • S. Oshima et al.

    Enhancement of muscle repair using human mesenchymal stem cells with a magnetic targeting system in a subchronic muscle injury model

    J. Orthop. Sci.

    (2014)
  • C. Wilhelm et al.

    Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells

    Biomaterials

    (2007)
  • Y. Yamamoto et al.

    Preparation of artificial skeletal muscle tissues by a magnetic force-based tissue engineering technique

    J. Biosci. Bioeng.

    (2009)
  • K. Shimizu et al.

    Mag-seeding of rat bone marrow stromal cells into porous hydroxyapatite scaffolds for bone tissue engineering

    J. Biosci. Bioeng.

    (2007)
  • A.W. Orr et al.

    Mechanisms of mechanotransduction

    Dev. Cell

    (2006)
  • D. Seo et al.

    A mechanogenetic toolkit for interrogating cell signaling in space and time

    Cell

    (2016)
  • N.T. Thanh

    Clinical Applications of Magnetic Nanoparticles: From Fabrication to Clinical Applications

    (2018)
  • N. Lee et al.

    Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy

    Chem. Rev.

    (2015)
  • B.H. Kim et al.

    Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents

    J. Am. Chem. Soc.

    (2011)
  • H. Wei et al.

    Exceedingly small iron oxide nanoparticles as positive MRI contrast agents

    Proc. Natl. Acad. Sci. U.S.A.

    (2017)
  • Y. Bao et al.

    Magnetic iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging

    J. Mater. Chem. C.

    (2018)
  • R. Hachani et al.

    Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents

    Nanoscale

    (2016)
  • H.L. Chee et al.

    Biocompatible peptide-coated ultrasmall superparamagnetic iron oxide nanoparticles for in vivo contrast-enhanced magnetic resonance imaging

    ACS Nano

    (2018)
  • S. Miltenyi et al.

    High gradient magnetic cell separation with MACS

    Cytometry

    (1990)
  • B.D. Plouffe et al.

    Fundamentals and application of magnetic particles in cell isolation and enrichment: a review

    Rep. Prog. Phys.

    (2015)
  • N. Pamme et al.

    Continuous sorting of magnetic cells via on-chip free-flow magnetophoresis

    Lab Chip

    (2006)
  • N. Pamme

    Continuous flow separations in microfluidic devices

    Lab Chip

    (2007)
  • C.W. Shields et al.

    Microfluidic cell sorting: a review of the advances in the separation of cells from debulking to rare cell isolation

    Lab Chip

    (2015)
  • J.H. Myung et al.

    Microfluidic devices to enrich and isolate circulating tumor cells

    Lab Chip

    (2015)
  • C. Derec et al.

    Local control of magnetic objects in microfluidic channels

    Microfluid. Nanofluidics

    (2009)
  • M. Johannsen et al.

    Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution

    Eur. Urol.

    (2007)
  • M. Johannsen et al.

    Magnetic nanoparticle hyperthermia for prostate cancer

    Int. J. Hyperther.

    (2010)
  • K. Maier-Hauff et al.

    Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme

    J. Neuro Oncol.

    (2007)
  • K. Maier-Hauff et al.

    Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

    J. Neuro Oncol.

    (2011)
  • D. Niculaes et al.

    Asymmetric assembling of iron oxide nanocubes for improving magnetic hyperthermia performance

    ACS Nano

    (2017)
  • G. Hemery et al.

    Monocore vs. multicore magnetic iron oxide nanoparticles: uptake by glioblastoma cells and efficiency for magnetic hyperthermia

    Mol. Syst. Des. Eng.

    (2017)
  • A. Espinosa et al.

    Magnetic (Hyper)Thermia or photothermia? Progressive comparison of iron oxide and gold nanoparticles heating in water, in cells, and in vivo

    Adv. Funct. Mater.

    (2018)
  • G.R. Souza et al.

    Three-dimensional tissue culture based on magnetic cell levitation

    Nat. Nanotechnol.

    (2010)
  • F. Mazuel et al.

    Magnetic flattening of stem-cell spheroids indicates a size-dependent elastocapillary transition

    Phys. Rev. Lett.

    (2015)
  • D. Fayol et al.

    Use of magnetic forces to promote stem cell aggregation during differentiation, and cartilage tissue modeling

    Adv. Mater.

    (2013)
  • A.C. Daquinag et al.

    Adipose tissue engineering in three-dimensional levitation tissue culture system based on magnetic nanoparticles

    Tissue Eng. C Methods

    (2012)
  • V. Du et al.

    A 3D magnetic tissue stretcher for remote mechanical control of embryonic stem cell differentiation

    Nat. Commun.

    (2017)
  • B. Shah et al.

    Multimodal magnetic core-shell nanoparticles for effective stem-cell differentiation and imaging

    Angew Chem. Int. Ed. Engl.

    (2013)
  • L.M. Bystrom et al.

    Iron and reactive oxygen species: friends or foes of cancer cells?

    Antioxidants Redox Signal.

    (2012)
  • F. Mazuel et al.

    Massive intracellular biodegradation of iron oxide nanoparticles evidenced magnetically at single-endosome and tissue levels

    ACS Nano

    (2016)
  • Cited by (49)

    • Concurrent magnetic and thermal energy storage using a novel phase-change microencapsulated-nanoparticles fluid

      2022, Journal of Energy Storage
      Citation Excerpt :

      Phase-change microcapsules with magnetic functions can meet the needs of military infrared electromagnetic double shielding characteristics, greatly improving material operability. In recent years, the study of magnetic nanoparticles has attracted widespread interest in various disciplines, mainly in the fields of magnetic fluids [16], biomedicine [17], and nuclear magnetic resonance imaging [18]. Magnetic nanoparticles have many special magnetic properties, such as superparamagnetic and high coercivity [19].

    • Magnetic nanoparticles – A new era in nanotechnology

      2022, Journal of Drug Delivery Science and Technology
      Citation Excerpt :

      They can be stabilized by coating the surfaces with various compounds that are organic and inorganic biocompatible compounds such as polymers, metals, metal oxides, silica, and so on [1]. Recently, numerous investigations have been carried out that demonstrate the contribution of MNPs in the fields of regenerative medicine and tissue engineering, where they are used to spatially arrange and activate cells using their magneto-mechanical capabilities [2]. MNPs can be employed in the treatment of cancer by magnetic hyperthermia/heat generation that uses an alternating magnetic field (AMF) and is presently under clinical investigation as another approach to treating prostate cancer and glioblastoma (malignant tumor affecting the brain or spine) [2].

    • Tension exerted on cells by magnetic nanoparticles regulates differentiation of human mesenchymal stem cells

      2022, Biomaterials Advances
      Citation Excerpt :

      For more precisely controlled conditions, in addition to the 3 control groups (without MNP and/or MF), the gene expression level depending upon the initial seeding concentration of the cells (Supplementary Fig. 6) and the gene expression level in the uniform MF(UMF), without a field gradient, using a Helmholtz coil (Supplementary Fig. 7) were measured and then compared. The electromagnetic fields may also have had an effect on differentiation or proliferation [53–58]. Nevertheless, the control group (MF only or MNPs only) showed no statistically significant effect on osteogenic differentiation (Figs. 2, 3).

    • Combination therapy using nanomaterials and stem cells to treat spinal cord injuries

      2022, European Journal of Pharmaceutics and Biopharmaceutics
    View all citing articles on Scopus
    View full text